LAB - Standard BioTools Inc
IEX Last Trade
2.125
0.045 2.118%
Share volume: 2,219,587
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.08
0.05
2.16%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-09 | 2023-03-14 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-01 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 441.122 M | 414.915 M | 390.310 M | 371.654 M | 355.827 M | 339.285 M | 323.067 M | 777.667 M | |
| Current Assets | 250.877 M | 229.017 M | 208.815 M | 194.928 M | 183.070 M | 170.741 M | 158.215 M | 547.565 M | |
| Inventories | 22.791 M | 21.946 M | 21.473 M | 22.513 M | 22.080 M | 21.927 M | 20.533 M | 40.359 M | |
| Other Current Assets | 5.938 M | 4.609 M | 4.278 M | 3.374 M | 3.567 M | 3.404 M | 3.127 M | 8.912 M | |
| Short Term Investments | 5.938 M | 4.609 M | 4.278 M | 3.374 M | 3.567 M | 3.404 M | 3.127 M | 8.912 M | |
| Total Receivables | 10.937 M | 17.294 M | 17.280 M | 14.504 M | 15.119 M | 16.560 M | 19.660 M | 36.012 M | |
| Current Cash | 211.211 M | 185.168 M | 165.784 M | 154.537 M | 142.304 M | 128.850 M | 114.895 M | 462.282 M | |
| Total Non-current Assets | 190.245 M | 185.898 M | 181.495 M | 176.726 M | 172.757 M | 168.544 M | 164.852 M | 230.102 M | |
| Property Plant Equipment | 27.275 M | 26.584 M | 25.652 M | 25.002 M | 24.522 M | 24.538 M | 24.187 M | 44.786 M | |
| Other Assets | 3.158 M | 3.119 M | 3.109 M | 2.665 M | 2.754 M | 2.390 M | 2.285 M | 21.287 M | |
| Intangible Assets | 18.200 M | 15.400 M | 12.600 M | 9.800 M | 7.000 M | 4.200 M | 1.400 M | 24.794 M | |
| Goodwill | 106.200 M | 106.069 M | 106.251 M | 106.285 M | 106.287 M | 106.225 M | 106.317 M | 106.269 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 441.122 M | 414.915 M | 390.310 M | 371.654 M | 355.827 M | 339.285 M | 323.067 M | 777.667 M | |
| Total liabilities | 167.323 M | 166.409 M | 160.524 M | 157.554 M | 157.961 M | 159.752 M | 159.865 M | 200.351 M | |
| Total current liabilities | 42.770 M | 46.169 M | 43.443 M | 43.787 M | 46.840 M | 51.800 M | 109.327 M | 121.554 M | |
| Accounts Payable | 9.016 M | 9.305 M | 7.914 M | 6.109 M | 6.089 M | 7.327 M | 9.236 M | 13.141 M | |
| Other liabilities | 22.624 M | 20.866 M | 19.136 M | 17.830 M | 17.179 M | 16.195 M | 15.340 M | 46.549 M | |
| Current long term debt | 0.000 | 833.000 K | 2.083 M | 3.333 M | 4.583 M | 5.000 M | 59.530 M | 54.656 M | |
| Long term debt | 64.546 M | 63.885 M | 62.809 M | 61.734 M | 60.662 M | 59.590 M | 3.983 M | 299.000 K | |
| Other liabilities | 22.624 M | 20.866 M | 19.136 M | 17.830 M | 17.179 M | 16.195 M | 15.340 M | 46.549 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 273.799 M | 248.506 M | 229.786 M | 214.100 M | 197.866 M | 179.533 M | 163.202 M | 577.316 M | |
| Common stock | 77.821 M | 78.897 M | 79.471 M | 79.080 M | 78.669 M | 79.152 M | 79.739 M | 294.125 M | |
| Retained earnings | -875.825 M | -905.251 M | -926.096 M | -942.939 M | -959.979 M | -980.976 M | -1.001 B | -1.079 B |